MedTrace Logo

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

NCT07789119 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2026-08-27

No results posted yet for this study

Summary

To collect, process, store, and study biological samples and related clinical and imaging data from participants with known or suspected urothelial carcinoma or another related malignancy of the urinary tract.

Conditions

  • Prospective Collection
  • Molecular Analysis
  • Biospecimens
  • Urothelial Carcinoma (UC)
  • Urinary Tract

Interventions

DIAGNOSTIC_TEST

biospecimen Collection

biospecimen collection during routine care encounters or clinically indicated procedures

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Byron Lee, MD · UT MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-02-06
Primary Completion
2036-12-31
Completion
2038-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07789119 on ClinicalTrials.gov